Chaushev Borislav, Micheva Ilina, Mechmed Merilin, Balev Boyan, Bocheva Yana, Ivanova Darina, Krasnaliev Ivan, Lozanova Rumena, Klisarova Anelia, Bochev Pavel, Dancheva Jivka
Department of Nuclear Medicine and Metabolic Therapy MBAL ``St. Marina``, Varna.
Nucl Med Rev Cent East Eur. 2016;19(B):11-13. doi: 10.5603/NMR.2016.0029.
Extranodal lymphoma, secondary to or accompanying nodal disease is uncommon, but not unusual finding. 18-Fluorodeoxyglucose positron emission tomography (18F-FDG PET/CT) imaging has an essential role in the staging of lymphoma, in treatment response monitoring, and in detection of recurrence. We present a case of a 52-year-old man with generalized diffuse large B-cell lymphoma (DLBCL) with multiple extranodal sites involvement detected by 18F-FDG PET/CT. With this clinical case we demonstrate that 18F-FDG PET-CT is a more effective technique than CE-CT for the evaluation of viable extranodal involvement of the diffuse large B-cell lymphoma (DLBCL) and should be combined in the monitoring of DLBCL.
结外淋巴瘤继发于或伴随淋巴结疾病并不常见，但也并非罕见。18氟脱氧葡萄糖正电子发射断层扫描（18F-FDG PET/CT）成像在淋巴瘤分期、治疗反应监测及复发检测中起着重要作用。我们报告一例52岁男性，经18F-FDG PET/CT检测发现患有累及多个结外部位的弥漫性大B细胞淋巴瘤（DLBCL）。通过该临床病例，我们证明18F-FDG PET-CT在评估弥漫性大B细胞淋巴瘤（DLBCL）的结外活性受累方面比增强CT（CE-CT）更有效，应将其纳入DLBCL的监测中。
